Managing Asthma in St. Louis: It's Scary Not to Be Able to Breathe

Growing up, Jerica Gordon’s sister had asthma, but she does not remember her having any asthma attacks. “So when my son was having trouble breathing, I thought it was just congestion or something. There was no wheezing that I remember hearing,” she shared. In November 2016, Jerica took her son Jonathan Robinson, Jr., then age 5, to the emergency room.

Protect Yourself From Dust Mites With Asthma and Allergy Friendly Pillows and Pillow Covers

When you lay your head on your pillow at night, all you want to think about is comfort – not millions of dust mites. And if you have a dust mite allergy, having all those microscopic insects near your head can make you uncomfortable by triggering allergy and asthma symptoms. You can create a healthier sleeping environment by using pillows that are CERTIFIED asthma & allergy friendly®. Or you can cover your existing pillow in a CERTIFIED pillow cover.

New Digital Long-Term Control Inhaler Works With Smartphones to Help People Track Inhaler Use

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people with asthma.

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.

FDA Approves Dupixent® for Chronic Rhinosinusitis With Nasal Polyps

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity). This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps.

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).

AAFA Applauds DOT Warning About Denial of Preboarding to Family With Food Allergies

AAFA applauds the warning the U.S. Department of Transportation (USDOT) issued to American Airlines in response to American Airline’s denial of the right to pre-board a family of a child with food allergies. However, AAFA calls on the USDOT and Congress to take even stronger actions to protect the rights of airline passengers with allergies and all disabilities.

What Happens in Your Airways When You Have Asthma?

To understand asthma , a chronic disease that causes your airways to become inflamed, it helps to first know how your airways work. Watch on YouTube How Do Normal Airways Work? When we breathe in, air moves through our airways – from our nose or mouth, down a large hollow tube in the front of the neck called a windpipe or trachea – and into our lungs. The trachea divides into two tubes called bronchial [bron-KEE-uhl] tubes in the lungs. They look like upside-down trees. As the bronchial...

Post
×
×
×
×